Skip to main content
. 2022 Nov 25;8:138. doi: 10.1186/s40795-022-00639-z

Table 1.

Baseline characteristics of patients

RYR Placebo P-value
Age (years), mean ± SD 63 ± 8 64 ± 9 0.566
Male, n (%) 17 23 0.475
Statin, n (%)
 Atorvastatin 10 mg 3 7 0.671
 Atorvastatin 20 mg 16 14
 Atorvastatin 40 mg 4 9
 Rosuvastatin 5 mg 8 6
 Rosuvastatin 10 mg 4 3
 Rosuvastatin 20 mg 5 7
 Rosuvastatin 40 mg 3 3
TG (mg/dL), mean ± SD 133.6 ± 68.3 117.3 ± 63.6 0.23
Total cholesterol (mg/dL), mean ± SD 164.2 ± 34.4 147.1 ± 25 0.007
LDL cholesterol (mg/dL), mean ± SD 100.9 ± 24.2 87.4 ± 20.8 0.005
HDL cholesterol (mg/dL), mean ± SD 43.7 ± 10.1 42.6 ± 12.1 0.642
Hs-CRP (mg/dL), mean ± SD 1.59 ± 2.3 1.4 ± 2.16 0.78
Daily calories intake (kcal/day) 2340 ± 120 2297 ± 139 0.11

RYR Red yeast rice,SD Standard deviation, TG Triglyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, Hs-CRP High-sensitivity C-reactive protein